CAGENT VASCULAR
Cagent Vascular is a medical device company developing minimally invasive technologies to treat cardiovascular disease.
CAGENT VASCULAR
Industry:
Health Care Medical Device Wellness
Founded:
2014-01-01
Address:
Wayne, Pennsylvania, United States
Country:
United States
Website Url:
http://www.cagentvascular.com
Total Employee:
11+
Status:
Active
Contact:
610-688-2006
Email Addresses:
[email protected]
Total Funding:
21.87 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Mobile Non Scaleable Content Euro Microsoft Exchange Online
Similar Organizations
Cadent Therapeutics
Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.
HebeCell
HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases.
LivWell Enlightened Health
LivWell Enlightened Health is a medical cannabis company producing and retailing multi-state cannabis.
Magnamosis
Magnamosis develops a medical device designed to create a magnetic compression anastomosis with improved outcomes.
Mediflux
Mediflux offers medical devices to treat breath measurement and respiratory diseases.
metaMe Health
MetaMe Health develops FDA-cleared prescription digital therapeutics for the treatment of gastrointestinal conditions.
OrCam Technologies
OrCam harnesses the power of artificial vision in an intuitive portable device that compensates for lost visual abilities.
ReShape Lifesciences
ReShape Lifesciencesis a developer of minimally invasive medical devices to treat obesity and metabolic diseases.
Stel Life
Stel Life simplifies health device connectivity for patients, care teams, and device companies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Synergy Ventures
Synergy Ventures investment in Series B - Cagent Vascular
Balestier
Balestier investment in Series B - Cagent Vascular
Ben Franklin Technology Partners
Ben Franklin Technology Partners investment in Series B - Cagent Vascular
Ben Franklin Technology Partners of Southeastern Pennsylvania
Ben Franklin Technology Partners of Southeastern Pennsylvania investment in Seed Round - Cagent Vascular
Official Site Inspections
http://www.cagentvascular.com
- Host name: 104.21.64.214
- IP address: 104.21.64.214
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cagent Vascular"
About Cagent Vascular
Cagent Vascular is a team of medical device professionals who work diligently to develop new, high-quality, innovative technologies for physicians to use in treating patients.See details»
Cagent Vascular - Crunchbase Company Profile
Organization. Cagent Vascular . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number 610-688-2006; Cagent Vascular …See details»
Org Chart Cagent Vascular - The Official Board
The organizational chart of Cagent Vascular displays its 8 main executives including Brian Walsh, Aaron Green and Peter JohanssonSee details»
Cagent Vascular Company Profile 2024: Valuation, …
Cagent Vascular General Information Description. Developer of a next-generation intravascular technology designed to treat diseased peripheral arteries. The company's technology is a minimally invasive device for vessel dilatation in …See details»
Cagent Vascular - Overview, News & Similar companies - ZoomInfo
Cagent Vascular contact info: Phone number: (610) 688-2006 Website: www.cagentvascular.com What does Cagent Vascular do? Cagent Vascular's vision is to be the leader for treating …See details»
Cagent Vascular - LinkedIn
Cagent Vascular (Wayne, PA) has developed and commercialized its novel angioplasty balloon with Serration Technology to treat blocked arteries in the leg or Peripheral Artery Disease (PAD) and ...See details»
News - Cagent Vascular
May 7, 2024 To learn more about Cagent Vascular’s mission to fight PAD, visit www.cagentvascular.com. The information contained herein obtained from Cagent Vascular …See details»
Cagent Vascular Company Profile - Office Locations, Competitors …
Cagent Vascular has 5 employees at their 1 location and $12.37 m in total funding,. See insights on Cagent Vascular including office locations, competitors, revenue, financials, executives, …See details»
Cagent Vascular Raises $30 Million Series C Financing
WAYNE, Pa., February 20, 2024--Cagent Vascular, Inc., a rapidly growing commercial stage medical device company, today announced a Series C Financing close in excess of $30M. …See details»
Cagent Vascular Raises $11.87M to Fund the Growth and …
Jul 12, 2018 Cagent Vascular, LLC Lauren Pfeiffer, 610-688-2006 [email protected]. Contacts. Cagent Vascular, LLC Lauren Pfeiffer, 610-688-2006 [email protected]. …See details»
News - Cagent Vascular
Feb 20, 2024 Although angioplasty has been used clinically for over 50 years, there remain significant opportunities to optimize the therapy and to improve the treatment outcomes of …See details»
Sectoral Asset Management Makes $9M Investment into Cagent …
Jun 17, 2021 Lauren Pfeiffer at 610.688.2006 or [email protected] Release Summary Cagent Vascular Inc, a developer of serration angioplasty balloons, announced the investment …See details»
Cagent Vascular Raises Funds to Broaden Serranator PTA Catheter ...
February 20, 2024—Cagent Vascular, Inc. announced the close of a Series C financing of more than $30 million. The funds will be used to accelerate the United States market adoption and …See details»
Cagent Vascular Announces Commercial Launch of the Serranator …
Jun 1, 2022 Visit www.cagentvascular.com. This project is supported by the Ben Franklin Technology Partners of Southeastern PA, an initiative of the Pennsylvania Department of …See details»
Team of Experts - Cagent Vascular
From our medical professionals to our executives, we combine decades of cross-disciplinary experience.See details»
News - Cagent Vascular
Browse the latest updates in Cagent Vascular publications, business developments, press features, and study results.See details»
Cagent Vascular Announces FDA 510(k) Clearance for its …
Apr 23, 2020 Lauren Pfeiffer at 610.688.2006 or [email protected]. Contacts. Lauren Pfeiffer at 610.688.2006 or [email protected]. Site Navigation. Home. Home; Submit …See details»
Cagent Vascular announces superior lumen gain ... - Cardiac …
Jan 31, 2023 Lauren Pfeiffer at 610.688.2006 or [email protected]. Cagent Vascular; Ken Dropiewski. Ken has been in the cardiac, vascular, and interventional space for over 20 …See details»
Careers - Cagent Vascular
By submitting Send Message “Contact Us” form, your personal data will be processed by Cagent Vascular and its subsidiary entities worldwide.See details»